The difficult task of HLA Cinderellas – the HLA Supertypes approach

28/04/2021

The number of HLA alleles has been growing exponentially over the last couple of years (it just reached 30 000 in April 2021, IMGT 3.44, figure 1) and it looks like the curve is not stopping any time soon, which does not make the lives of scientists in the transplant...

Welcome Our New Distributor Partner!

22/04/2021

Omixon is pleased to announce a new distribution agreement with Syngen Biotech Sp. Z o.o. Sp. K. – a leading distributor of comprehensive equipment for laboratories throughout Poland. Syngen Biotech has been in the Polish market specializing in providing several high-class research equipment, diagnostics tests, reagents and offering application support...

Extension to the AzureSeq-200 CE One-step RT-qPCR Assay

26/03/2021

Omixon and SeqOnce Biosciences Announce an Extension to the AzureSeq-200 CE One-step RT-qPCR Assay to Detect SARS-CoV-2 E484K N501Y mutations and K417 wildtype Assay quickly identifies the E484K, N501Y mutations and K417 wildtype found in U.K., South Africa, and Brazil lineages of SARS-CoV-2 Transplantation was severely affected by the COVID...

HLA TWIN 4.4.1 – Software Update

26/03/2021

At Omixon, we are committed to continuously improving our products, correcting issues, and implementing fixes for software bugs with expediency in order to minimize the effects and eliminate disruptions in our customers’ workflow. Based on early feedback regarding HLA Twin we are pleased to inform you that all reported...

EFI 2021

11/03/2021

EFI 2021 | From Research To Clinical Reality The registration is already open, you can register and find more info HERE. The planned detailed program is available HERE. In order to arrange one-to-one discussions with any of our representatives, please contact them either in advance by sending an email to sales@omixon.com or...